Published in Surg Gynecol Obstet on June 01, 1991
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Radiology (2009) 1.08
Liver resection for breast cancer metastasis: does it improve survival? Surg Today (2008) 0.94
Treatment outcome of patients with liver-only metastases from breast cancer after mastectomy: a retrospective analysis. J Cancer Res Clin Oncol (2011) 0.92
Does liver resection provide long-term survival benefits for breast cancer patients with liver metastasis? A single hospital experience. Yonsei Med J (2014) 0.90
The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB (Oxford) (2016) 0.84
Aggressive treatment for hepatic metastases from breast cancer: results from a single center. World J Surg (2013) 0.82
Surgery for liver metastases from breast cancer. HPB (Oxford) (2006) 0.81
Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol (2008) 0.80
Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer. Semin Intervent Radiol (2008) 0.77
Prognostic factors related to surgical outcome of liver metastases of breast cancer. J Breast Cancer (2013) 0.77
Complete pathologic response of HER2-positive breast cancer liver metastasis with dual anti-HER2 antagonism. BMC Cancer (2014) 0.75
The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. Health Technol Assess (2002) 6.37
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Collecting morbidity data in general practice: the Somerset morbidity project. BMJ (1996) 3.08
The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess (1999) 2.83
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer (1999) 2.40
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg (1999) 2.37
Should women carry their antenatal records? Br Med J (Clin Res Ed) (1986) 2.17
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol (1996) 2.17
Postoperative pulmonary complications. Epidural analgesia using bupivacaine and opioids versus parenteral opioids. Anesthesiology (1993) 2.14
Surgical management of primary anorectal melanoma. Br J Surg (2004) 2.14
Prognostic importance of low c-erbB2 expression in breast tumors. J Natl Cancer Inst (1998) 2.00
A simple physicochemical micromethod for determining fixed anionic groups in connective tissue. Biochim Biophys Acta (1970) 1.98
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. Br J Cancer (1998) 1.96
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol (2003) 1.96
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol (2000) 1.95
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer (2001) 1.92
Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy. Br J Surg (1995) 1.88
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
A randomized controlled trial of the provision of a social support service during pregnancy: the South Manchester Family Worker Project. Br J Obstet Gynaecol (1989) 1.81
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg (1998) 1.79
Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol (2004) 1.79
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. Cancer (2001) 1.78
Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77
Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg (2002) 1.74
Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys (1985) 1.74
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71
Retrotransposon evolution in diverse plant genomes. Genetics (2000) 1.68
Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg (1995) 1.64
Catabolites of chlorophyll in senescing barley leaves are localized in the vacuoles of mesophyll cells. Proc Natl Acad Sci U S A (1988) 1.61
Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol (1989) 1.60
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Ann Oncol (2005) 1.54
A rational approach to shift work in emergency medicine. Ann Emerg Med (1992) 1.53
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Eur J Cancer (2004) 1.52
Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology (1996) 1.46
[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. Gastroenterol Clin Biol (1999) 1.45
Evidence in support of a role for plant-mediated proteolysis in the rumens of grazing animals. Br J Nutr (2005) 1.44
Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol (1998) 1.43
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg (2003) 1.42
[Adenocarcinomas of the breast in women under 30]. Bull Cancer (1973) 1.42
Praziquantel. Med Res Rev (1983) 1.41
Postoperative hypoxaemia: continuous extradural infusion of bupivacaine and morphine vs patient-controlled analgesia with intravenous morphine. Br J Anaesth (1998) 1.39
[What are the real indications for hepatectomies in metastases of colorectal origin?]. Gastroenterol Clin Biol (1998) 1.39
[Perianesthetic management of carcinoid syndrome: contribution of the bispectral EEG index]. Ann Fr Anesth Reanim (2000) 1.38
What proportion of isotope injected does the child receive in dynamic renal scanning? Nucl Med Commun (1992) 1.38
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol (1995) 1.36
Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol (2000) 1.36
Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer (1989) 1.35
Hepatitis B variant in Europe. Lancet (1988) 1.31
Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg (1995) 1.29
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol (2007) 1.29
Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol (1998) 1.26
Recent advances: oncology. BMJ (1999) 1.26
The efficacy of praziquantel against cestodes in animals. Z Parasitenkd (1977) 1.26
Prolonged intermittent clamping of the portal triad during hepatectomy. Br J Surg (1991) 1.25
Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med (1988) 1.25
Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut (2005) 1.24
De novo evolution of satellite DNA on the rye B chromosome. Genetics (2000) 1.24
Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut (2003) 1.23
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer (2004) 1.22
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group. J Clin Oncol (1999) 1.22
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. Eur J Cancer (1994) 1.21
Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol (1996) 1.21
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer (1988) 1.20
Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer (1998) 1.19
Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int J Cancer (1987) 1.17
Chronic cough in a hospital population; its relationship to atopy and defects in host defence. Arch Dis Child (1989) 1.16
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res (1988) 1.16
Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer (2000) 1.15
Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology (1987) 1.15
The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol (1987) 1.14
Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol (2004) 1.14
Liver abscess formation after local treatment of liver tumors. Hepatology (1996) 1.13
Evaluation of an integrated community antenatal clinic. J R Coll Gen Pract (1987) 1.13
Action of caffeine on calcium transport by isolated fractions of myofibrils, mitochondria, and sarcoplasmic reticulum from rabbit heart. Circ Res (1978) 1.11
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut (2003) 1.11
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat (2013) 1.10
[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]. Bull Cancer (1999) 1.10
Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer. Clin Cancer Res (1999) 1.10
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09
Preparation of insoluble collagen from human cartilage. Biochem J (1973) 1.09
Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol (2006) 1.08
Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol (2001) 1.08
Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol (1988) 1.07
Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. Int J Tuberc Lung Dis (2001) 1.07
Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology (1993) 1.06
Demonstration of the ascending aorta in infective endocarditis by intravenous digital subtraction angiography. Br Heart J (1988) 1.06
[Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis]. Ann Dermatol Venereol (1999) 1.06
Multistep ionization of argon clusters in intense femtosecond extreme ultraviolet pulses. Phys Rev Lett (2008) 1.06
Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol (1995) 1.05
Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat (1989) 1.05
Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol (1986) 1.05